Three-dimensional Structure of a Mutant HIV-1 Protease Displaying Cross-resistance to All Protease Inhibitors in Clinical Trials (Q54162409)

25 May 2018

http://europepmc.org/abstract/MED/7665551

title

Three-dimensional Structure of a Mutant HIV-1 Protease Displaying Cross-resistance to All Protease Inhibitors in Clinical Trials (English)

1 reference

https://api.crossref.org/works/10.1074/JBC.270.37.21433

31 July 2024

author name string

Z. Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7665551

31 July 2024

Y. Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7665551

31 July 2024

H. B. Schock

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7665551

31 July 2024

D. Hall

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7665551

31 July 2024

E. Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7665551

31 July 2024

L. C. Kuo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7665551

31 July 2024

language of work or name

English

0 references

publication date

1 September 1995

1 reference

25 May 2018

http://europepmc.org/abstract/MED/7665551

15 September 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7665551

full work available at URL

31 July 2024

http://www.jbc.org/content/270/37/21433.full.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7665551

https://api.elsevier.com/content/article/PII:S0021925818901894?httpAccept=text/xml

31 July 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.270.37.21433

https://api.elsevier.com/content/article/PII:S0021925818901894?httpAccept=text/plain

31 July 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.270.37.21433

https://syndication.highwire.org/content/doi/10.1074/jbc.270.37.21433

31 July 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.270.37.21433

Journal of Biological Chemistry

31 July 2024

published in

1 reference

25 May 2018

http://europepmc.org/abstract/MED/7665551

volume

270

1 reference

25 May 2018

http://europepmc.org/abstract/MED/7665551

issue

37

1 reference

25 May 2018

http://europepmc.org/abstract/MED/7665551

page(s)

21433-21436

1 reference

25 May 2018

http://europepmc.org/abstract/MED/7665551

cites work

Human immunodeficiency virus. Protease uninhibited

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.37.21433

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.37.21433

High-level resistance to zidovudine but not to zalcitabine or didanosine in human immunodeficiency virus from children receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.37.21433

L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.37.21433

Host strain selection for bacterial expression of toxic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.37.21433

Dissociation and association of the HIV-1 protease dimer subunits: equilibria and rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.37.21433

The three-dimensional structure of the aspartyl protease from the HIV-1 isolate BRU

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.37.21433

Structure-based inhibitors of HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.37.21433

Alpha-chymotrypsin: a case study of substituent constants and regression analysis in enzymic structure--activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.37.21433

Functional group contributions to drug-receptor interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.37.21433

Structural basis of drug resistance for the V82A mutant of HIV-1 proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.37.21433

21 January 2018

Identifiers

1 reference

25 May 2018

http://europepmc.org/abstract/MED/7665551

1 reference

25 May 2018